Cargando…

Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome

BACKGROUND: Insulin resistance is core cause of metabolic syndrome. Determining insulin resistance is one of the foremost requirements imperative to understanding the pathophysiology of disease. The gold standard “Euglycaemic clamp test” is cumbersome, long and non-feasible in routine clinical setup...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Sikandar Hayat, Khan, Ali Nawaz, Chaudhry, Nayyer, Anwar, Roomana, Fazal, Nadeem, Tariq, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570930/
https://www.ncbi.nlm.nih.gov/pubmed/31223343
http://dx.doi.org/10.1186/s13098-019-0439-5
_version_ 1783427329176895488
author Khan, Sikandar Hayat
Khan, Ali Nawaz
Chaudhry, Nayyer
Anwar, Roomana
Fazal, Nadeem
Tariq, Muhammad
author_facet Khan, Sikandar Hayat
Khan, Ali Nawaz
Chaudhry, Nayyer
Anwar, Roomana
Fazal, Nadeem
Tariq, Muhammad
author_sort Khan, Sikandar Hayat
collection PubMed
description BACKGROUND: Insulin resistance is core cause of metabolic syndrome. Determining insulin resistance is one of the foremost requirements imperative to understanding the pathophysiology of disease. The gold standard “Euglycaemic clamp test” is cumbersome, long and non-feasible in routine clinical setups to diagnose metabolic syndrome. Various continuous and steady state insulin resistance indices are now available in literature. We plan to evaluate commonly utilized steady state insulin resistance indices directly and Homeostasis Model Assessment for Insulin Resistance (HOMAIR) with added triglyceride (HOMA-TG index). METHODS: The cross-sectional study was carried from Jan-2016 to Dec-2018 at PNS HAFEEZ and department of chemical pathology, AFIP with following objectives: (1) To evaluate steady state insulin resistance markers for diagnosing metabolic syndrome as per IDF defined criteria by ROC curve analysis, (2) to measure Kendal Concordance between various insulin resistance indices and (3) to correlate steady state insulin resistance markers with anthropometric and lipid indices. After several exclusions we selected 224 subjects based upon “non-probability convenience sampling” for inclusion in study. Clinical history, anthropometric measures were calculated and sampling was done for insulin, glucose and other biochemical parameters. Metabolic syndrome was diagnosed as per IDF criteria, while HbA1c was utilized to diagnose diabetes mellitus. Pearson correlation was used to correlate various steady state insulin resistance indices including HOMAIR, HOMA2 index, QUICKI, G/I ratio, HOMA-TG index and serum insulin. AUC was calculated by ROC analysis for all surrogate insulin measures in diagnosis of metabolic syndrome. RESULTS: “HOMA-TG index” has shown the highest AUC for diagnosing metabolic syndrome along with higher correlation with lipid markers and anthropometric indices in comparison to other steady-state insulin resistance markers. Furthermore, QUICKI and G/I ratio showed the lowest AUC for detection of metabolic syndrome. CONCLUSION: “HOMA-TG index” has shown highest AUC for metabolic syndrome diagnosis. However, QUICKI and G/I ration showed the lowest AUC for detection of metabolic syndrome. It is hoped that the potential “HOMA-TG index” may provide better diagnostic efficiency for diagnosing metabolic syndrome.
format Online
Article
Text
id pubmed-6570930
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65709302019-06-20 Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome Khan, Sikandar Hayat Khan, Ali Nawaz Chaudhry, Nayyer Anwar, Roomana Fazal, Nadeem Tariq, Muhammad Diabetol Metab Syndr Research BACKGROUND: Insulin resistance is core cause of metabolic syndrome. Determining insulin resistance is one of the foremost requirements imperative to understanding the pathophysiology of disease. The gold standard “Euglycaemic clamp test” is cumbersome, long and non-feasible in routine clinical setups to diagnose metabolic syndrome. Various continuous and steady state insulin resistance indices are now available in literature. We plan to evaluate commonly utilized steady state insulin resistance indices directly and Homeostasis Model Assessment for Insulin Resistance (HOMAIR) with added triglyceride (HOMA-TG index). METHODS: The cross-sectional study was carried from Jan-2016 to Dec-2018 at PNS HAFEEZ and department of chemical pathology, AFIP with following objectives: (1) To evaluate steady state insulin resistance markers for diagnosing metabolic syndrome as per IDF defined criteria by ROC curve analysis, (2) to measure Kendal Concordance between various insulin resistance indices and (3) to correlate steady state insulin resistance markers with anthropometric and lipid indices. After several exclusions we selected 224 subjects based upon “non-probability convenience sampling” for inclusion in study. Clinical history, anthropometric measures were calculated and sampling was done for insulin, glucose and other biochemical parameters. Metabolic syndrome was diagnosed as per IDF criteria, while HbA1c was utilized to diagnose diabetes mellitus. Pearson correlation was used to correlate various steady state insulin resistance indices including HOMAIR, HOMA2 index, QUICKI, G/I ratio, HOMA-TG index and serum insulin. AUC was calculated by ROC analysis for all surrogate insulin measures in diagnosis of metabolic syndrome. RESULTS: “HOMA-TG index” has shown the highest AUC for diagnosing metabolic syndrome along with higher correlation with lipid markers and anthropometric indices in comparison to other steady-state insulin resistance markers. Furthermore, QUICKI and G/I ratio showed the lowest AUC for detection of metabolic syndrome. CONCLUSION: “HOMA-TG index” has shown highest AUC for metabolic syndrome diagnosis. However, QUICKI and G/I ration showed the lowest AUC for detection of metabolic syndrome. It is hoped that the potential “HOMA-TG index” may provide better diagnostic efficiency for diagnosing metabolic syndrome. BioMed Central 2019-06-14 /pmc/articles/PMC6570930/ /pubmed/31223343 http://dx.doi.org/10.1186/s13098-019-0439-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Khan, Sikandar Hayat
Khan, Ali Nawaz
Chaudhry, Nayyer
Anwar, Roomana
Fazal, Nadeem
Tariq, Muhammad
Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome
title Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome
title_full Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome
title_fullStr Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome
title_full_unstemmed Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome
title_short Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome
title_sort comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570930/
https://www.ncbi.nlm.nih.gov/pubmed/31223343
http://dx.doi.org/10.1186/s13098-019-0439-5
work_keys_str_mv AT khansikandarhayat comparisonofvarioussteadystatesurrogateinsulinresistanceindicesindiagnosingmetabolicsyndrome
AT khanalinawaz comparisonofvarioussteadystatesurrogateinsulinresistanceindicesindiagnosingmetabolicsyndrome
AT chaudhrynayyer comparisonofvarioussteadystatesurrogateinsulinresistanceindicesindiagnosingmetabolicsyndrome
AT anwarroomana comparisonofvarioussteadystatesurrogateinsulinresistanceindicesindiagnosingmetabolicsyndrome
AT fazalnadeem comparisonofvarioussteadystatesurrogateinsulinresistanceindicesindiagnosingmetabolicsyndrome
AT tariqmuhammad comparisonofvarioussteadystatesurrogateinsulinresistanceindicesindiagnosingmetabolicsyndrome